AMPLIFIDX INC

PLEASANTON, CA · Founded 2020 · CIK 0001874159 · Medtech · Private

Rapid molecular diagnostic platform for fast, accurate test results

amplifidx.com →
Grants
$580K
2 awards
Sector median: 1
Raised
$329K
1 Form D · Jul 2021
62 months since last filing
Contracts
$400K
1 award · Health and Human S
#397 of 4531 in medtech
Patents
3
0 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$329,396
Federal contractDepartment of Health and Human Services · Phs 2022-1 Topic 440 - Cancer Prevention & Diagnosis Technologies For Low-resource Settings$400,000
Federal grantDepartment of Health and Human Services · Phase I · STI NG Plus, a Swab to Answer Molecular Panel Test for Point of Care Diagnosis and Treatment Recommendation$286,775
Federal grantDepartment of Health and Human Services · Phase I · STI NG Plus, a Swab to Answer Molecular Panel Test for Point of Care Diagnosis and Treatment Recommendation$293,189
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
394HESPEROS, INC$434K—
395ZMK Medical Technologies, Inc.$422K—
396Nanalysis Corp.$411K$15K
397AMPLIFIDX INC$400K$329K
398Oncobiomix Inc.$400K$150K
399QUANTITATIVE IMAGING SYSTEMS LLC$400K—
400ACOUSTIIC, INC.$400K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Sammy DatwaniDirector
  • Bruce SargeantDirector
  • Nancy SchoenbrunnerDirector · Executive Officer
  • Ming TanDirector

Patents

USPTO · 0 granted of 3
  • Point-of-care Bioassay Systems And Methods Of Making And Using The Sameapplication
  • Point-of-care Bioassay Systems And Methods Of Making And Using The Sameapplication
  • Point-of-care Bioassay Systems And Methods Of Making And Using The Sameapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.